A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption-Reference-Cited by-同舟云学术

A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption

Published:2012-03 Issue:3 Volume:142 Page:252-268
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

Allard Sabine D.,De Keersmaecker Brenda,de Goede Anna L.,Verschuren Esther J.,Koetsveld Jeanette,Reedijk Mariska L.,Wylock Carolien,De Bel Annelies V.,Vandeloo Judith,Pistoor Frank,Heirman Carlo,Beyer Walter E.P.,Eilers Paul H.C.,Corthals Jurgen,Padmos Iman,Thielemans Kris,Osterhaus Albert D.M.E.,Lacor Patrick,der Ende Marchina E. van,Aerts Joeri L.,van Baalen Carel A.,Gruters Rob A.

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference88 articles.

1. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators;Palella;N. Engl. J. Med.,1998

2. The challenge of finding a cure for HIV infection;Richman;Science,2009

3. Therapeutic vaccines against HIV need international partnerships;Autran;Nat. Rev. Immunol.,2003

4. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy;Finzi;Nat. Med.,1999

5. HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression;Pitcher;Nat. Med.,1999

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Applications of cell therapy in the treatment of virus-associated cancers;Nature Reviews Clinical Oncology;2024-08-19

2. Leveraging oncovirus-derived antigen against the viral malignancies in adoptive cell therapies;Biomarker Research;2024-07-29

3. Potential Application of Modified mRNA in Cardiac Regeneration;Cell Transplantation;2024-01

4. Effects of Injectable Solutions on the Quality of Monocyte‐Derived Dendritic Cells for Immunotherapy;Journal of Immunology Research;2024-01

5. Electroporation of mRNA as a Universal Technology Platform to Transfect a Variety of Primary Cells with Antigens and Functional Proteins;Methods in Molecular Biology;2024